Tafamidis significantly increases rosuvastatin exposure, increasing risk of myopathy and rhabdomyolysis.
Source: NLP:rosuvastatin calcium
1 interaction on record
Tafamidis significantly increases rosuvastatin exposure, increasing risk of myopathy and rhabdomyolysis.
Source: NLP:rosuvastatin calcium